MEI Pharma (NASDAQ: MEIP) has announced a major step into the world of cryptocurrency. The company has launched a $100 million Litecoin treasury strategy. The move is supported by Titan Partners Group and crypto investment fund GSR. The idea is to provide MEI Pharma with a powerful balance sheet by means of digital assets and open new opportunities.
This announcement stirred the market up very fast. At the moment of the news, the stock price of MEIP soared up to 11.45 in comparison to the previously standing price of 4.20. Nonetheless, it fell again to the $6 level when trading representatives were responding to the some euphoria and confusion of this huge shift.
The role of Charlie Lee in this plan is one of the most significant ones. He is the founder of Litecoin and of the many respected individuals in the cryptocurrency universe. He will now be part of the Board of Directors at MEI Pharma. This move indicates the firm commitment of MEI in establishing its future affiliation with Litecoin.
As well as Lee has taken a new responsibility, the Litecoin Foundation itself is also an investor in MEI Pharma. The mission of the Foundation is the promotion of Litecoin throughout the world. This collaboration is an ideal combination with this purpose. The Litecoin Foundation opines that Litecoin should not only be used on an individual level but must also be relied upon by companies and large investors.
Charlie Lee believes that Litecoin enabled the population to transfer money reasonably and inexpensively over the years. It is used by many to shop, transfer money to other countries and to pay via services such as BitPay. Under the current plan of MEI Pharma now, this use is predicted to expand into the larger corporations and enormous finance as well.
Titan Partners Group and GSR are leading the way in this transformation. They think that businesses must not use a single cryptocurrency. Treasuries use bitcoin, but recently companies are also looking into altcoins. These are Ethereum, Dogecoin, Solana (SOL), and so on. MEI Pharma is looking forward to becoming one of the first publicly traded companies to make a large treasury position in Litecoin.
Since Charlie Lee created Litecoin in 2011, he has been instrumental in its development. He contributed to introducing new elements into Litecoin such as its privacy and enabling Segregated Witness (SegWit. This was an improvement that also affected the development of Bitcoin. Lee also sponsors such significant projects as the Lightning Network and other laboratories that develop tools of Litecoin and Bitcoin.
Lee aims to make the use of Litecoin even more real by collaborating with MEI Pharma. He feels that this collaboration will demonstrate that Litecoin can be relied upon not only by the people, but also by businesses that have a large responsibility to investors and regulators.
In the future, the daring step of MEI Pharma may encourage other businesses to pursue the same approach. Crypto treasury is not limited to Bitcoin anymore. With even more companies experimenting with altcoins, such as Litecoin, the whole market can receive new attention from traditional investors.
At this point, MEI Pharma is in the spotlight to watch how this $100 million Litecoin plan would work out. The company has powerful partners and a well-established crypto pioneer on its board, and it is attempting to show that digital assets can create sustainable value in the future of a publicly traded company.
Read more on Live Bitcoin News
